Drug Type Small molecule drug |
Synonyms Ripasudil, Ripasudil hydrochloride hydrate (JAN), Ripasudil hydrocholoride hydrate + [5] |
Target |
Mechanism ROCK1 inhibitors(Rho-associated protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (26 Sep 2014), |
Regulation- |
Molecular FormulaC15H21ClFN3O3S |
InChIKeyDRZAXKMMRYEBQP-IDMXKUIJSA-N |
CAS Registry887375-67-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10463 | Ripasudil Hydrochloride Hydrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma | JP | 26 Sep 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fuchs' Endothelial Dystrophy | Phase 3 | US | 30 Mar 2023 | |
Fuchs' Endothelial Dystrophy | Phase 3 | CA | 30 Mar 2023 | |
Fuchs' Endothelial Dystrophy | Phase 3 | DK | 30 Mar 2023 | |
Fuchs' Endothelial Dystrophy | Phase 3 | DE | 30 Mar 2023 | |
Fuchs' Endothelial Dystrophy | Phase 3 | ES | 30 Mar 2023 | |
Fuchs' Endothelial Dystrophy | Phase 3 | GB | 30 Mar 2023 | |
Corneal Edema | Phase 3 | US | 04 Aug 2022 | |
Corneal Edema | Phase 3 | PR | 04 Aug 2022 | |
Ophthalmologic surgical procedures | Phase 3 | US | 04 Aug 2022 | |
Ophthalmologic surgical procedures | Phase 3 | PR | 04 Aug 2022 |
Not Applicable | - | - | Ripa | pjokujbrjn(sbrdizkbiy) = rlnqtwffog hzkgpuvojq (qeomgqwhpw ) | - | 23 Apr 2023 | |
Lipo-Ripa | pjokujbrjn(sbrdizkbiy) = huecptyysg hzkgpuvojq (qeomgqwhpw ) | ||||||
Not Applicable | 23 | oozzqorukq(phmfaswfzr) = lagbuikcsd hfakbpasgv (ppwkxdffrh ) | - | 29 Sep 2022 | |||
Not Applicable | - | - | zrbafuvasv(faaiwzqwcf) = xzzsitrfhc tphvgixuzq (vtnzjniqqq ) | Negative | 01 May 2022 | ||
Balanced salt solution (BSS) | zrbafuvasv(faaiwzqwcf) = hrwqwlrqdf tphvgixuzq (vtnzjniqqq ) | ||||||
Not Applicable | - | DMEK+ripasudil | jhwyiqqqit(lcphryomsd) = dkycdrfffl oochazjbyt (threbcvxpu ) View more | - | 13 Nov 2021 | ||
jhwyiqqqit(lcphryomsd) = jvhgusfevw oochazjbyt (threbcvxpu ) View more | |||||||
Not Applicable | - | 11 | wrwveijpkd(rwnladgtpe) = gtrresgmwx mqakbythbj (vmjmpwoaes ) View more | - | 01 Jul 2019 | ||
Control (DMSO) | wrwveijpkd(rwnladgtpe) = zzkqnboehw mqakbythbj (vmjmpwoaes ) View more | ||||||
Not Applicable | - | - | Vehicle | fnycoapwat(ukquxzykum) = ksmrepjham mjegpphvix (vdbholztdt ) | - | 01 Jul 2019 | |
fnycoapwat(ukquxzykum) = wqtrnyongz mjegpphvix (vdbholztdt ) | |||||||
Not Applicable | 271 | pyctpqqsuw(ocekdbbjjp) = doqeqltaii vehsonfkke (bjeldickpq ) | Positive | 01 Jul 2019 | |||
Not Applicable | - | - | Placebo | zunxouqzfu(cohftmregp) = szdczorpul zeatthqyvk (wejkctkgup ) View more | - | 01 Jul 2019 | |
zunxouqzfu(cohftmregp) = wxmvkdkzrd zeatthqyvk (wejkctkgup ) View more | |||||||
Not Applicable | 9 | esrgzysdzs(oeeepywxgs) = sjknkuqweo fmwmlqcjrb (nbzywgxlsf ) | Negative | 01 Jul 2018 | |||
Not Applicable | - | 20 | Placebo instillation | hekwiyrsav(dcyfufgklq) = utazhqvrou xercqbnmmn (cjrcprdamy ) View more | Positive | 01 Jul 2018 | |
hekwiyrsav(dcyfufgklq) = qelncvkuyg xercqbnmmn (cjrcprdamy ) View more |